Genetic Difference in Susceptibility to the Blood-retina Barrier Breakdown in Diabetes and Oxygen-induced Retinopathy

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2005 Jan 6

PMID 15632023

Citations 52

Authors

Sarah X Zhang

Jian-Xing Ma

Jing Sima

Ying Chen

Mark S Hu

Anna Ottlecz

George N Lambrou

Affiliations

Soon will be listed here.

Abstract

The breakdown of the blood-retina barrier (BRB) is a common feature of diabetic retinopathy. The purpose of the present study is to determine whether there are genetic differences in susceptibility to the breakdown of the BRB in diabetic retinopathy using two rat models. In streptozotocin (STZ)-induced diabetes, Brown Norway (BN) rats developed sustained vascular hyperpermeability in the retina during the entire experimental period (16 weeks of diabetes), while diabetic Sprague Dawley (SD) rats only showed retinal hyperpermeability from 3 to 10 days after the onset of diabetes. The strain difference in permeability was not correlated with the blood glucose levels in these two strains. In oxygen-induced retinopathy (OIR), BN rats developed retinal vascular hyperpermeability from postnatal day 12 (P12) to P22 with a peak at P16, which was 8.7-fold higher than that in the age-matched normal controls. In OIR-SD rats, however, hyperpermeability was observed from P14 to P18, with a peak only 2.2-fold higher than that in the controls. The strain difference in vascular hyperpermeability was correlated with the different overexpression of vascular endothelial growth factor (VEGF) in the retina of these two models. This finding suggests that genetic backgrounds contribute to the susceptibility to diabetic retinopathy.

Citing Articles

A Systematic Review of the Neuroprotective Effects of Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy and Diabetic Macular Edema: Unraveling the Molecular Mechanisms and Clinical Implications.

Yadav M, Grezenko H, Kanukollu V, Rehman A, Bokhari S, Reza T Cureus. 2024; 15(12):e51351.

PMID: 38288195 PMC: 10824587. DOI: 10.7759/cureus.51351.

Diabetes-Induced Changes of the Rat ERG in Relation to Hyperglycemia and Acidosis.

Dmitriev A, Dmitriev A, Linsenmeier R Curr Eye Res. 2023; 49(1):53-61.

PMID: 37756520 PMC: 10872866. DOI: 10.1080/02713683.2023.2264544.

A Method for Real-Time Assessment of Mitochondrial Respiration Using Murine Corneal Biopsy.

Liang W, Huang L, Yuan T, Cheng R, Takahashi Y, Moiseyev G Invest Ophthalmol Vis Sci. 2023; 64(11):33.

PMID: 37642632 PMC: 10476441. DOI: 10.1167/iovs.64.11.33.

Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.

Qu Q, Park K, Zhou K, Wassel D, Farjo R, Criswell T Front Cell Dev Biol. 2023; 10:1049678.

PMID: 36589744 PMC: 9802579. DOI: 10.3389/fcell.2022.1049678.

Gingerol, a Natural Antioxidant, Attenuates Hyperglycemia and Downstream Complications.

Alharbi K, Nadeem M, Afzal O, Alzarea S, Altamimi A, Almalki W Metabolites. 2022; 12(12).

PMID: 36557312 PMC: 9782005. DOI: 10.3390/metabo12121274.

References

Lightman S, Pinter G, Yuen L, Bradbury M . Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition. Am J Physiol. 1990; 259(3 Pt 2):R601-5. DOI: 10.1152/ajpregu.1990.259.3.R601. View

Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K . The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest. 1996; 74(4):819-25. View

Adamis A . Is diabetic retinopathy an inflammatory disease?. Br J Ophthalmol. 2002; 86(4):363-5. PMC: 1771111. DOI: 10.1136/bjo.86.4.363. View

Kihara M, Schmelzer J, Poduslo J, Curran G, Nickander K, Low P . Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci U S A. 1991; 88(14):6107-11. PMC: 52031. DOI: 10.1073/pnas.88.14.6107. View

Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J . Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001; 489(2-3):270-6. DOI: 10.1016/s0014-5793(01)02110-x. View

Antonetti D, Barber A, Khin S, Lieth E, Tarbell J, Gardner T . Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998; 47(12):1953-9. DOI: 10.2337/diabetes.47.12.1953. View

Smith L, Wesolowski E, McLellan A, Kostyk S, Damato R, Sullivan R . Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35(1):101-11. View

Yoshida A, Ishiko S, Kojima M, Ogasawara H . Permeability of the blood-ocular barrier in adolescent and adult diabetic patients. Br J Ophthalmol. 1993; 77(3):158-61. PMC: 504461. DOI: 10.1136/bjo.77.3.158. View

Gardner T, Antonetti D, Barber A, LaNoue K, Levison S . Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2003; 47 Suppl 2:S253-62. DOI: 10.1016/s0039-6257(02)00387-9. View

10.

Hammes H, Lin J, Bretzel R, Brownlee M, Breier G . Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998; 47(3):401-6. DOI: 10.2337/diabetes.47.3.401. View

11.

Kinoshita N, Kakehashi A, Inoda S, Itou Y, Kuroki M, Yasu T . Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide. Diabetologia. 2002; 45(5):735-9. DOI: 10.1007/s00125-002-0820-y. View

12.

Zhang D, Kaufman P, Gao G, Saunders R, Ma J . Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia. 2001; 44(6):757-65. DOI: 10.1007/s001250051685. View

13.

Poulaki V, Qin W, Joussen A, Hurlbut P, Wiegand S, Rudge J . Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest. 2002; 109(6):805-15. PMC: 150907. DOI: 10.1172/JCI13776. View

14.

Granstam E, Granstam S . Regulation of uveal and retinal blood flow in STZ-diabetic and non-diabetic rats; involvement of nitric oxide. Curr Eye Res. 1999; 19(4):330-7. DOI: 10.1076/ceyr.19.4.330.5300. View

15.

Ennis S . Permeability of the blood-ocular barrier to mannitol and PAH during experimental diabetes. Curr Eye Res. 1990; 9(9):827-38. DOI: 10.3109/02713689008999555. View

16.

Berkowitz B, Roberto K, Penn J . The vitreous protein concentration is increased prior to neovascularization in experimental ROP. Curr Eye Res. 1998; 17(2):218-21. DOI: 10.1076/ceyr.17.2.218.5604. View

17.

Berkowitz B, Kowluru R, Frank R, Kern T, Hohman T, Prakash M . Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999; 40(9):2100-5. View

18.

Kowluru R . Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res. 2002; 24(2):123-8. DOI: 10.1076/ceyr.24.2.123.8158. View

19.

Carroll W, Hollis T, Gardner T . Retinal histamine synthesis is increased in experimental diabetes. Invest Ophthalmol Vis Sci. 1988; 29(8):1201-4. View

20.

Joussen A, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S . Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002; 16(3):438-40. DOI: 10.1096/fj.01-0707fje. View